Ascend Wellness Holdings (AAWH) EBIT (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly EBIT came in at $2.5 million in Q1 2026, up 2.41% year-on-year from $2.5 million in Q1 2025, and up 114.83% quarter-over-quarter from -$17.2 million in Q4 2025.
Ascend Wellness Holdings (AAWH) EBIT (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' EBIT history runs 7 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- On a quarterly basis, EBIT rose 2.41% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was -$17.0 million, a 464.95% decrease from a year earlier, with the FY2025 full-year figure at -$17.0 million, down 459.36% from the prior year.
- EBIT climbed to $2.5 million in Q1 2026 per AAWH's latest filing, from -$17.2 million in the prior quarter.
- Across five years, EBIT topped out at $6.1 million in Q4 2024 and bottomed at -$17.2 million in Q4 2025.
- The 5-year median for EBIT is $255000.0 (2023), against an average of -$1.2 million.
- Across the five-year window, EBIT tumbled 1219.83% in 2023 and jumped 981.21% in 2024, its largest moves.
- Year by year, EBIT stood at $5.4 million in 2022, then plunged by 89.52% to $564000.0 in 2023, then soared by 981.21% to $6.1 million in 2024, then tumbled by 381.58% to -$17.2 million in 2025, then jumped by 114.83% to $2.5 million in 2026.
- Per Business Quant, the three latest AAWH EBIT figures stand at $2.5 million (Q1 2026), -$17.2 million (Q4 2025), and -$1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | -17.17 Mn |
| Sep 30, 2025 | -1.33 Mn |
| Jun 30, 2025 | -1.00 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 6.10 Mn |
| Sep 30, 2024 | -2.42 Mn |
| Jun 30, 2024 | -1.52 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 564,000.00 |
| Sep 30, 2023 | 3.55 Mn |
| Jun 30, 2023 | -7.99 Mn |
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | -605,000.00 |
| Mar 31, 2022 | -14.78 Mn |
| Dec 31, 2021 | -731,000.00 |
| Sep 30, 2021 | 11.61 Mn |
| Jun 30, 2021 | 3.90 Mn |